StockData
Disc Medicine, Inc. logo

Disc Medicine, Inc. (IRON) stock

IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$76.57−0.02 (-0.03%)

Close on Nov 17, 2026Market cap $2.94BP/E –Yield –

Disc Medicine cash

Cash and short-term investments held at the end of each period.

Disc Medicine's cash was $717.70M at Jun 30, 2026. For fiscal 2025 it was $791.20M, up 61.5% from the year before. The highest annual figure on record is $791.20M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$791.20M+61.5%
FY2024Dec 31, 2024$489.90M+35.9%
FY2023Dec 31, 2023$360.62M+85.1%
FY2022Dec 31, 2022$194.79M+120.8%
FY2021Dec 31, 2021$88.21M+240.8%
FY2020Dec 31, 2020$25.89M+682.3%
FY2019Dec 31, 2019$3.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$717.70M+10.4%
Q1 FY2026Mar 31, 2026$730.20M+5.1%
Q4 FY2025Dec 31, 2025$791.20M+61.5%
Q3 FY2025Sep 30, 2025$615.90M+26.4%
Q2 FY2025Jun 30, 2025$650.00M+29.8%
Q1 FY2025Mar 31, 2025$694.70M+102.6%
Q4 FY2024Dec 31, 2024$489.90M+35.9%
Q3 FY2024Sep 30, 2024$487.40M+31.5%
Q2 FY2024Jun 30, 2024$500.90M+32.6%
Q1 FY2024Mar 31, 2024$342.85M+44.9%
Q4 FY2023Dec 31, 2023$360.62M+85.1%
Q3 FY2023Sep 30, 2023$370.66M+566.1%
Q2 FY2023Jun 30, 2023$377.72M+478.1%
Q1 FY2023Mar 31, 2023$236.60M+217.7%
Q4 FY2022Dec 31, 2022$194.79M+120.8%
Q3 FY2022Sep 30, 2022$55.65M-63.0%
Q2 FY2022Jun 30, 2022$65.34M-61.1%
Q1 FY2022Mar 31, 2022$74.47M-59.8%
Q4 FY2021Dec 31, 2021$88.21M+240.8%
Q3 FY2021Sep 30, 2021$150.39M+1010.9%
Q2 FY2021Jun 30, 2021$167.80M+2482.3%
Q1 FY2021Mar 31, 2021$185.31M+1270.4%
Q4 FY2020Dec 31, 2020$25.89M+682.3%
Q3 FY2020Sep 30, 2020$13.54M–
Q2 FY2020Jun 30, 2020$6.50M–
Q1 FY2020Mar 31, 2020$13.52M–
Q4 FY2019Dec 31, 2019$3.31M–

More Disc Medicine figures

See a number that looks wrong?